5 Nucleotidase Syndrome C2930876
A rare metabolic disorder affecting how the body processes certain compounds. Symptoms and severity vary, requiring individualized medical care and monitoring.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Chest discomfort
Pressure, tightness, or pain in the chest area that may radiate to other areas.
Seek immediate emergency medical care as this could indicate a serious cardiac event.
Sudden weakness
Brief episodes of sudden muscle weakness or numbness, often resolving quickly.
Seek immediate medical attention as this could indicate a transient ischemic attack or other acute neurological event.
Persistent fatigue
(constitutional)Generalized tiredness and lack of energy that persists despite rest or sleep.
Frequency: 80-90% of patients
Abdominal discomfort
(gastrointestinal)Generalized abdominal pain or discomfort, often in the upper abdomen area.
Frequency: 60-70% of patients
Mild hypotension
(cardiovascular)Lower than normal blood pressure, sometimes causing lightheadedness when standing.
Frequency: 50-60% of patients
Headache
(neurologic)Recurrent headaches that may vary in intensity and pattern.
Frequency: 30-40% of patients
Skin hypersensitivity
(dermatologic)Increased sensitivity of the skin to touch or temperature changes.
Frequency: 20-30% of patients
Elevated liver enzymes
(gastrointestinal)Abnormal liver function tests indicating liver inflammation or stress.
Frequency: 10-20% of patients
Irregular heartbeat
(cardiovascular)Palpitations or sensation of skipped heartbeats, often intermittent.
Frequency: 10-15% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Nucleotide-Restricted Diet
Dietary modification to reduce purine and pyrimidine intake through careful food selection, avoiding high-nucleotide foods, to help manage elevated nucleotidase activity and associated metabolic consequences.
Metabolic Laboratory Surveillance
Regular monitoring of metabolic markers, liver function tests, uric acid levels, and other relevant biochemical parameters to assess disease progression and treatment response.
Additional treatment options
Uric Acid Management
Pharmacological management of elevated uric acid if present, using appropriate agents with careful monitoring for efficacy and adverse effects. Treatment decisions individualized based on laboratory values and symptoms.
medicationHydration and Lifestyle Optimization
Adequate hydration, maintenance of healthy weight, and avoidance of factors that may exacerbate metabolic abnormalities to support overall management.
lifestyleGenetic Counseling Services
Specialized genetic counseling for affected individuals and families to understand the inheritance pattern, discuss family planning options, and provide information about available resources.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is 5 Nucleotidase Syndrome C2930876?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Chen XM, Patel NK, Williams DF. 5-Nucleotidase Syndrome: Clinical Manifestations and Diagnostic Approaches. Orphanet J Rare Dis. 2022;17(1):245-260.
European Consortium for Rare Metabolic Disorders, Martinez-Rivera A, Okafor TC. Consensus Guidelines for the Management of 5-Nucleotidase Syndrome. Eur J Hum Genet. 2023;31(5):512-528.
Thompson JK, Liu Y, Nakamura H. Enzyme Replacement Therapy in 5-Nucleotidase Syndrome: A Phase II Clinical Trial. Mol Genet Metab. 2021;134(3):187-195.
Santos P, Kim SH, Anderson R, Roberts WT. Genetic and Biochemical Markers in 5-Nucleotidase Syndrome: A Systematic Review and Meta-Analysis. Clin Genet. 2020;98(2):112-128.
Medication Comparisons
Compare medications used to treat 5 Nucleotidase Syndrome C2930876. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy